At a glance
Summary
CVS Health gained 6.3% in the latest week and is up 43.8% over 12 weeks, keeping its Trend Signal active for a sixth straight week. The move is supported by unusually strong Healthcare Plans breadth, although volume confirmation is still moderate and the stock now trades well above both its Trend Line and Fair Value marker.
- CVS closed at $102.00, up 6.3% for the week and positioned at 98.2% of its 52-week range.
- The Trend Signal is active, with 44 active weeks out of the past 52 and a current 6-week streak.
- Price sits 26.6% above the $80.51 Trend Line and 55.7% above the $65.47 Fair Value reading, showing strong demand but a richer risk profile.
- Volume reached 46.3M shares, 1.2x the 13-week average of 39.8M, enough to confirm participation but not a high-conviction volume expansion.
- Healthcare Plans remains much stronger than broader Healthcare, with 81.8% trend breadth versus 33.0% for the sector.
Company analysis
The move in context
Weekly tape and signal state
CVS Health ended the week at $102.00, a 6.3% gain that matched its four-week return and left the stock just below its $102.80 52-week high. The longer look is stronger: the 12-week advance stands at 43.8%, while the 52-week return is 56.6%, placing CVS in the upper fifth of the US Healthcare peer universe at roughly the 80th percentile.
The Trend Signal remains active and has now been on for six consecutive weeks, with trend activity present in 44 of the past 52 weeks. Market Dynamics is positive at 1.18, and Relative Strength has improved to 21.54, but the signal panel still shows no fresh buy from Market Dynamics and an undecided expectation reading at 53.76%. That leaves the weekly structure constructive, but not free of confirmation risk.
Sector and industry context
The stock’s move is occurring in a split Healthcare tape. The broad US Healthcare group gained an average 0.8% for the week and 7.9% over 12 weeks, with only 33.0% trend breadth and 31.0% positive Relative Strength breadth. CVS is far ahead of that sector pace, particularly on the 12-week view.
The industry picture is more demanding. US Healthcare Plans averaged an 8.8% weekly gain and 66.9% over 12 weeks, with 81.8% trend breadth and 90.9% positive Market Dynamics breadth. CVS ranked fifth in the 11-stock industry group for the week, behind sharper moves in names such as Alignment Healthcare, Clover Health, Oscar Health and Humana. In other words, CVS is strong versus Healthcare overall, but its industry peers are setting a faster short-term benchmark.
Price, valuation distance and volume
The price structure is stretched but orderly. CVS is 26.6% above its $80.51 Trend Line and 55.7% above its $65.47 Fair Value reading, which signals persistent premium demand. The close at 98.2% of the 52-week range leaves little distance to the high, so follow-through now matters more than recovery evidence.
Volume was supportive without being emphatic. The latest week traded 46.3M shares, compared with a 13-week average of 39.8M and a 52-week average of 38.2M, putting both ratios at 1.2x. That is better than quiet participation, but it falls short of the heavier turnover that would make a near-high breakout more persuasive.
Risk and what to watch next
Risk is not flashing a dominant top-level cluster, but the setup is no longer early. Thirteen-week volatility is 4.9%, above the 52-week reading of 4.0%, and the stock has logged 20 downside weeks versus 32 upside weeks over the past year. Average weekly gains of 3.5% have exceeded average losses of 3.1%, which helps explain the trend persistence, but also raises the bar for continued upside after a 43.8% quarter.
The next weekly test is whether CVS can stay near the high while maintaining positive Market Dynamics and improving volume. A move through the 52-week high on stronger participation would strengthen the continuation case, while a fade back toward the Trend Line would shift attention to how much of the recent premium demand is durable.
Peer comparison
How the wider group is behaving
Breadth shows how much of the sector or industry is participating. A company move is more convincing when its peers are improving too.
US Healthcare
100 tracked companiesAbove Trend Line33.0%
Positive Relative Strength31.0%
US Healthcare Plans
11 tracked companiesAbove Trend Line81.8%
Positive Relative Strength81.8%
Balanced view
What supports the case, and what could weaken it
What is working
- Trend Signal is active with a 6-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Market Dynamics is positive on the latest completed week.
- Latest weekly return ranks in the strongest part of its sector group.
What needs caution
- No major top-level risk cluster is currently dominant.
Research note
This article is for educational market research only and is not financial, investment, trading, tax, or legal advice. Sharemaestro does not make buy, sell, or hold recommendations.
Source and attribution
Source: Sharemaestro. Canonical article: https://sharemaestro.com/news/cvs-yearly-range-managed-care-breadth/.
Follow new Sharemaestro research through the RSS feed or JSON feed.